podcasts Ratings /ratings/en/research-insights/podcasts/the-s-p-pharma-dose-episode-29-just-when-you-thought-it-was-safe-to-go-back-in-the-water-amazon-buys-pillpack content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

In This List

The S&P Pharma Dose - Episode 29: Just When You Thought It Was Safe to Go Back In the Water - Amazon Buys PillPack

COMMENTS

COVID-19 Impact: Key Takeaways From Our Articles

COMMENTS

ESG Concerns In Oil And Gas Sectors Led To A Surge In Downgrade Pressure In January, Which Was Realized By Mid-February

COMMENTS

As European Hotels Grapple With Prolonged Restrictions, Are Operators And Landlords Sharing The Pain?

COMMENTS

Pharma Outlook: Eighth Straight Year Of Credit Deterioration In 2021

Listen: The S&P Pharma Dose - Episode 29: Just When You Thought It Was Safe to Go Back In the Water - Amazon Buys PillPack

Managing Director, Bob Schulz from S&P Global's retail team and Director, Tulip Lim, of the healthcare team drop in on the show to share thoughts on Amazon's recent no-longer-a-rumor move into the pharmacy space. What does it mean for the pharmaceutical supply chain? How concerned should we be from a ratings standpoint for the pharmacy chains and pharma wholesalers?

Register with S&P Global Ratings

Register now to access exclusive content, events, tools, and more.

Go Back